SOW
PVLA

State of Wyoming’s Palvella Therapeutics PVLA Stock Holding History

State of Wyoming’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
+879
New +$107K 0.01% 1271

Other funds holding PVLA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CAM
Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

State of Wyoming's PVLA Position: Q2 2026 in Review

State of Wyoming opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 879 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #1271 among its holdings.

63 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • State of Wyoming held 879 shares of Palvella Therapeutics worth $134K as of Q2 2026.
  • Palvella Therapeutics was a new State of Wyoming position in Q2 2026.
  • Palvella Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1271 holding.
  • 63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.